New app helps diabetes patients stay on track with insulin

NCT ID NCT05893797

Completed Disease control Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a connected insulin management platform in 36 people with type 1 or type 2 diabetes who use insulin. The goal was to see if the platform helped them take their insulin doses on time and keep their blood sugar in a healthy range. Participants used a continuous glucose monitor and the platform to track their progress.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES TYPE 2 DIABETES TYPE 2 DIABETES TREATED WITH INSULIN

Contacts and locations

Locations

CHU - l'Assistance Publique - Hôpitaux de Marseille

Marseille, 13005, France
CHU Strasbourg-Hautepierre

Strasbourg, Alsace, 67098, France
CHU de Besancon Hopital Jean Minjoz

Besançon, 25030, France
CHU de Caen Hôpital Cote de Nacre

Caen, Cedex 9, 14033, France
CHU de Lyon

Lyon, 69008, France
Centre Hospitalier Sud Francilien-Pharmacie

Corbeil-Essonnes, 91100, France
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet

Nice, 6202, France
Chu de Grenoble

Grenoble Cédex 9, 38043, France
Groupe Hospitalier Mutualiste Les Portes du Sud

Vénissieux, 69200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.